课题基金 / 基金详情

SUBSTRATE SPECIFICITY OF NONRECEPTOR TYROSINE KINASES

SUBSTRATE SPECIFICITY OF NONRECEPTOR TYROSINE KINASES
非受体酪氨酸激酶的底物特异性
批准号:
3460643
负责人:
W Todd MILLER
金额:
$9.79万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-09-01 至 1998-08-31

项目摘要

项目成果

W Todd MILLER的其他基金

相似基金

相关文献

中文摘要
翻译
劳斯肉瘤病毒引起的细胞转化和肿瘤形成是 依赖于病毒V-src基因的表达。 这个产品 基因是60千道尔顿的酪氨酸蛋白激酶,命名为v-Src。 同样,Abelson鼠白血病病毒的转化基因( 导致体内B细胞淋巴瘤)编码酪氨酸蛋白激酶 命名为v-Abl。 该建议的重点是蛋白质-蛋白质相互作用的作用, v-Src和v-Abl酪氨酸激酶的功能。 有人建议 非受体酪氨酸的Src同源(SH)区域2和3 激酶在激酶活性的调节和 对细胞基质的识别。 v-Src和v-Abl的区域, 参与分子内或分子间识别 通过基于肽的光亲和标记实验。 肽底物 含有光活性氨基酸的这些酶的类似物 对苯甲酰基-Phe将用作亲和标记。 改质区域 内部和外部的SH 2和SH 3域将进一步研究, 定点诱变,突变酶将通过在 用含酪氨酸的合成肽进行体外磷酸化。 这些 结果将与三维模型相关联 结构的v-Src的基础上最近的晶体结构的催化 cAMP依赖性蛋白激酶的结构域。 确定决定因素, 赋予野生型识别的v-Src的蛋白质底物 和突变酶,合成肽“文库”将用于选择 这些肽通过v-Src产生最大磷酸化。 突变型v-Src激酶将用于研究体内底物识别。 用于这些研究的模型系统将是转染有以下的Rat-1细胞: 编码具有改变的特异性的激酶的v-Src构建体。 基板 突变酶的识别将通过三个标准进行评估: 对总酪氨酸磷酸化的影响, 磷脂酶C-γ和其他特异性底物, 细胞转化 这些研究的目的是描述在一个 分子水平的步骤导致形成的“信号 复合物”在信号转导和致癌作用中起核心作用, 转型
英文摘要
Cellular transformation and tumor formation by Rous sarcoma virus is dependent on the expression of the viral v-src gene. The product of this gene is a 60-kilodalton tyrosine protein kinase designated as v-Src. Likewise, the transforming gene of Abelson murine leukemia virus (which causes B-cell lymphomas in vivo) encodes a tyrosine protein kinase designated as v-Abl. This proposal focuses on the role of protein-protein interactions in the function of the v-Src and v-Abl tyrosine kinases. It has been suggested that the Src homology (SH) regions 2 and 3 of nonreceptor tyrosine kinases are important both in the regulation of kinase activity and in the recognition of cellular substrates. Regions of v-Src and v-Abl which are involved in intra- or intermolecular recognition will be identified by peptide-based photoaffinity labelling experiments. Peptide substrate analogs for these enzymes containing the photoactive amino acid p-benzoyl-Phe will be used as the affinity labels. Modified regions inside and outside the SH2 and SH3 domains will be studied further by site-directed mutagenesis, and the mutant enzymes will be tested by in vitro phosphorylation with tyrosine-containing synthetic peptides. These results will be correlated with a model of the three-dimensional structure of v-Src based on the recent crystal structure of the catalytic domain of the cAMP-dependent protein kinase. To identify determinants in protein substrates for v-Src which confer recognition by the wild-type and mutant enzymes, synthetic peptide "libraries" will be used to select those peptides which give maximal phosphorylation by v-Src. Mutant v-Src kinases will be used to study in vivo substrate recognition. The model system for these studies will be Rat-1 cells transfected with v-Src constructs encoding kinases with altered specificity. Substrate recognition by the mutant enzymes will be assessed by three criteria: effects on total tyrosine phosphorylation, effects on phosphorylation of phospholipase C-gamma and other specific substrates, and effects on cellular transformation. The goal of these studies is to describe at a molecular level the steps leading to the formation of the "signalling complexes" which play a central role in signal transduction and oncogenic transformation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nonreceptor tyrosine kinases in Systemic Lupus Erythematosus
Nonreceptor tyrosine kinases in Systemic Lupus Erythematosus
Nonreceptor tyrosine kinases in Systemic Lupus Erythematosus
Structural and biochemical studies of the insulin and IGF1 receptors
  • 批准号:
    10266022
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2015
  • 负责人:
    W Todd MILLER
  • 依托单位:
海外基金